---
title: "Jibeier Pharmaceutical: Results of Phase III Clinical Trial for New Antidepressant JJH201501 Released"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/263461559.md"
description: "Jibeier Pharmaceutical announced that the Phase III clinical trial results of its antidepressant new drug JJH201501 have been released. The trial was designed as a randomized, double-blind, placebo-controlled, and positive-controlled study, with a total of 525 participants. The results showed that the 10mg and 15mg dosage groups had significantly better efficacy in treating depression compared to the placebo group, and were comparable to the 20mg group of hydrobromide vortioxetine tablets"
datetime: "2025-10-30T08:45:24.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/263461559.md)
  - [en](https://longbridge.com/en/news/263461559.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/263461559.md)
---

# Jibeier Pharmaceutical: Results of Phase III Clinical Trial for New Antidepressant JJH201501 Released

Jibeier Pharmaceutical announced that the new antidepressant JJH201501 currently under development has completed Phase III clinical trials. The trial employed a randomized, double-blind, placebo-controlled, multi-center design, with four groups: a 10mg trial drug group, a 15mg trial drug group, a placebo group, and a positive control group. Each of the 10mg trial drug group, 15mg trial drug group, and placebo group included 150 subjects, while the positive control group included 75 subjects, totaling 525 subjects who underwent an 8-week double-blind trial. The results showed that after 8 weeks of continuous administration, the clinical efficacy of the 10mg and 15mg JJH201501 tablet groups in treating depression was significantly better than that of the placebo group, with statistical significance, and comparable to the 20mg group of hydrobromide vortioxetine tablets

### Related Stocks

- [688566.CN](https://longbridge.com/en/quote/688566.CN.md)

## Related News & Research

- [Cocoa Prices Sink as the Global Supply Outlook Improves](https://longbridge.com/en/news/286797386.md)
- [BEZOS: THIS ISN'T ANYONE'S FAULT BUT GOVT POLICY](https://longbridge.com/en/news/287065227.md)
- [Rising Bond Yields Weigh on Stocks](https://longbridge.com/en/news/286939009.md)
- [Oil little changed as traders await breakthrough in US.-Iran negotiations](https://longbridge.com/en/news/286925961.md)
- [Bond yields look attractive but might stay volatile](https://longbridge.com/en/news/286892571.md)